The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938

Journal of Physiology

Volumn 593, Issue 17, 2015, Pages 3943-3957

  Perez Burgos, Azucena ^a   Wang, Lu ^b   Mcvey Neufeld, Karen Anne ^a   Mao, Yu Kang ^a   Ahmadzai, Mustafa ^c   Janssen, Luke J ^c   Stanisz, Andrew M ^a   Bienenstock, John ^a,d   Kunze, Wolfgang A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c ST JOSEPH S HOSPITAL   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6 IODONORDIHYDROCAPSAICIN; CALCIUM ION; CAPSAICIN; PROBIOTIC AGENT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST; TRPV1 RECEPTOR; VANILLOID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CHANNEL GATING; CONTROLLED STUDY; CULTURE MEDIUM; DRUG TARGETING; FACILITATION; FLUORESCENCE ANALYSIS; GASTROINTESTINAL PAIN; IN VIVO STUDY; INHIBITION KINETICS; JEJUNUM; KNOCKOUT MOUSE; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MALE; MESENTERY; MOUSE; NERVE CELL CULTURE; NERVE CELL EXCITABILITY; NERVE CELL STIMULATION; NERVE POTENTIAL; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE RELAXATION; SPINAL CORD NERVE CELL; SPINAL GANGLION; STOMACH DISTENSION; VAGOTOMY; ANALGESIA; ANIMAL; BRADYCARDIA; COMPLICATION; GENETICS; INNERVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL NERVE; SPRAGUE DAWLEY RAT; STOMACH DISEASES;

ANALGESIA; ANIMALS; BRADYCARDIA; CAPSAICIN; GANGLIA, SPINAL; JEJUNUM; LACTOBACILLUS REUTERI; MALE; MESENTERY; MICE, KNOCKOUT; PROBIOTICS; RATS, SPRAGUE-DAWLEY; SPINAL NERVES; STOMACH DISEASES; TRPV CATION CHANNELS;

EID: 84940600556     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP270229     Document Type: Article

References (74)

1. Abraham C & Cho JH (2009). Inflammatory bowel disease. N Engl J Med 361, 2066-2078.
2. Ait-Belgnaoui A, Eutamene H, Houdeau E, Bueno L, Fioramonti J & Theodorou V (2009). Lactobacillus farciminis treatment attenuates stress-induced overexpression of Fos protein in spinal and supraspinal sites after colorectal distension in rats. Neurogastroenterol Motil 21, 567-573, e518-569.
3. Akbar A, Yiangou Y, Facer P, Walters J, Anand P & Ghosh S (2008). Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 57, 923-929.
4. Al-Nedawi K, Mian MF, Hossain N, Karimi K, Mao YK, Forsythe P, Min KK, Stanisz AM, Kunze WA & Bienenstock J (2015). Gut commensal microvesicles reproduce parent bacterial signals to host immune and enteric nervous systems. FASEB J 29, 684-695.
5. Bercik P, Verdu E, Foster J, Macri J, Potter M, Huang X, Malinowski P, Jackson W, Blennerhassett P, Neufeld K, Lu J, Khan W, Corthesy-Theulaz I, Cherbut C, Bergonzelli G & Collins S (2010). Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 39, 2102-2112.
6. Berthoud HR, Blackshaw LA, Brookes SJ & Grundy D (2004). Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol Motil 16 Suppl 1, 28-33.
7. Bielefeldt K, Zhong F, Koerber HR & Davis BM (2006). Phenotypic characterization of gastric sensory neurons in mice. Am J Physiol Gastrointest Liver Physiol 291, G987-G997.
8. Bluthe RM, Michaud B, Kelley KW & Dantzer R (1996). Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. Neuroreport 7, 1485-1488.
9. Boesmans W, Owsianik G, Tack J, Voets T & Vanden Berghe P (2011). TRP channels in neurogastroenterology: opportunities for therapeutic intervention. Br J Pharmacol 162, 18-37.
10. 2 receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat. Gastroenterology 121, 358-369.
11. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J & Cryan JF (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108, 16050-16055.
12. Brierley SM, Carter R, Jones W 3rd, Xu L, Robinson DR, Hicks GA, Gebhart GF & Blackshaw LA (2005). Differential chemosensory function and receptor expression of splanchnic and pelvic colonic afferents in mice. J Physiol 567, 267-281.
13. Brierley SM, Page AJ, Hughes PA, Adam B, Liebregts T, Cooper NJ, Holtmann G, Liedtke W & Blackshaw LA (2008). Selective role for TRPV4 ion channels in visceral sensory pathways. Gastroenterology 134, 2059-2069.
14. Btesh J, Fischer MJ, Stott K & McNaughton PA (2013). Mapping the binding site of TRPV1 on AKAP79: implications for inflammatory hyperalgesia. J Neurosci 33, 9184-9193.
15. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD & Julius D (1997). The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389, 816-824.
16. Cervero F (1994). Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev 74, 95-138.
17. Collins S, Verdu E, Denou E & Bercik P (2009). The role of pathogenic microbes and commensal bacteria in irritable bowel syndrome. Dig Dis 27 Suppl 1, 85-89.
18. Cortright DN & Szallasi A (2004). Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem 271, 1814-1819.
19. Cryan JF & O'Mahony SM (2011). The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil 23, 187-192.
20. Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, O'Mahony S, Shanahan F & Keeling PW (2006). Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 130, 304-311.
21. Docherty RJ, Yeats JC, Bevan S & Boddeke HW (1996). Inhibition of calcineurin inhibits the desensitization of capsaicin-evoked currents in cultured dorsal root ganglion neurones from adult rats. Pflugers Arch 431, 828-837.
22. Duncker SC, Kamiya T, Wang L, Yang P & Bienenstock J (2011). Probiotic Lactobacillus reuteri alleviates the response to gastric distension in rats. J Nutr 141, 1813-1818.
23. Francavilla R, Miniello V, Magista AM, De Canio A, Bucci N, Gagliardi F, Lionetti E, Castellaneta S, Polimeno L, Peccarisi L, Indrio F & Cavallo L (2010). A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain. Pediatrics 126, e1445-1452.
24. Grundy D (2004). What activates visceral afferents? Gut 53 Suppl 2, ii5-8.
25. Haller D, Antoine JM, Bengmark S, Enck P, Rijkers GT & Lenoir-Wijnkoop I (2010). Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. J Nutr 140, 690S-697S.
26. Hillsley K & Grundy D (1998). Serotonin and cholecystokinin activate different populations of rat mesenteric vagal afferents. Neurosci Lett 255, 63-66.
27. Holzer P (2008). TRPV1: a new target for treatment of visceral pain in IBS? Gut 57, 882-884.
28. Holzer P (2011). Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol Ther 131, 142-170.
29. Hong S, Fan J, Kemmerer ES, Evans S, Li Y & Wiley JW (2009). Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat. Gut 58, 202-210.
30. Hosoi T, Okuma Y, Ono A & Nomura Y (2002). Subdiaphragmatic vagotomy fails to inhibit intravenous leptin-induced IL-1β expression in the hypothalamus. Am J Physiol Regul Integr Comp Physiol 282, R627-631.
31. Ibeakanma C, Ochoa-Cortes F, Miranda-Morales M, McDonald T, Spreadbury I, Cenac N, Cattaruzza F, Hurlbut D, Vanner S, Bunnett N, Vergnolle N & Vanner S (2011). Brain-gut interactions increase peripheral nociceptive signaling in mice with postinfectious irritable bowel syndrome. Gastroenterology 141, 2098-2108.
32. Kajander K, Hatakka K, Poussa T, Farkkila M & Korpela R (2005). A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 22, 387-394.
33. Kamiya T, Wang L, Forsythe P, Goettsche G, Mao Y, Wang Y, Tougas G & Bienenstock J (2006). Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 55, 191-196.
34. Kunze WA, Mao YK, Wang B, Huizinga JD, Ma X, Forsythe P & Bienenstock J (2009). Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening. J Cell Mol Med 13, 2261-2270.
35. Lamb K, Kang YM, Gebhart GF & Bielefeldt K (2003). Gastric inflammation triggers hypersensitivity to acid in awake rats. Gastroenterology 125, 1410-1418.
36. Long M & Drossman D (2010). Inflammatory bowel disease, irritable bowel syndrome, or what?: A challenge to the functional-organic dichotomy. Am J Gastroenterol 105, 1796-1798.
37. Ma X, Mao YK, Wang B, Huizinga JD, Bienenstock J & Kunze W (2009). Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am J Physiol Gastrointest Liver Physiol 296, G868-875.
38. MacDonald IA & Kuehn MJ (2012). Offense and defense: microbial membrane vesicles play both ways. Res Microbiol 163, 607-618.
39. Manichanh C, Borruel N, Casellas F & Guarner F (2012). The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9, 599-608.
40. Mao YK, Kasper DL, Wang B, Forsythe P, Bienenstock J & Kunze WA (2013). Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons. Nat Commun 4, 1465.
41. Mazzia C & Clerc N (1997). Ultrastructural relationships of spinal primary afferent fibres with neuronal and non-neuronal cells in the myenteric plexus of the cat oesophago-gastric junction. Neuroscience 80, 925-937.
42. McKendrick MW (1996). Post Salmonella irritable bowel syndrome-5 year review. J Infect 32, 170-171.
43. McKernan D, Fitzgerald P, Dinan T & Cryan J (2010). The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil 22, 1029-1035, e268.
44. + channels in intestinal afferent nerves. J Pharmacol Exp Ther 334, 566-575.
45. Morales-Lazaro SL, Simon SA & Rosenbaum T (2013). The role of endogenous molecules in modulating pain through transient receptor potential vanilloid 1 (TRPV1). J Physiol 591, 3109-3121.
46. Motulsky HJ & Neubig RR (2010). Analyzing binding data. Curr Protoc Neurosci Chapter 7, Unit 7.5.
47. O'Mahony C, van der Kleij H, Bienenstock J, Shanahan F & O'Mahony L (2009). Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am J Physiol Regul Integr Comp Physiol 297, R1118-1126.
48. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F & Quigley EM (2005). Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology 128, 541-551.
49. O'Mahony SM, Felice VD, Nally K, Savignac HM, Claesson MJ, Scully P, Woznicki J, Hyland NP, Shanahan F, Quigley EM, Marchesi JR, O'Toole PW, Dinan TG & Cryan JF (2014). Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience 277c, 885-901.
50. Ozaki N & Gebhart GF (2001). Characterization of mechanosensitive splanchnic nerve afferent fibers innervating the rat stomach. Am J Physiol Gastrointest Liver Physiol 281, G1449-1459.
51. Page AJ, Brierley SM, Martin CM, Price MP, Symonds E, Butler R, Wemmie JA & Blackshaw LA (2005). Different contributions of ASIC channels 1a, 2, and 3 in gastrointestinal mechanosensory function. Gut 54, 1408-1415.
52. Perez-Burgos A, Mao YK, Bienenstock J & Kunze WA (2014). The gut-brain axis rewired: adding a functional vagal nicotinic "sensory synapse". FASEB J 28, 3064-3074.
53. Perez-Burgos A, Wang B, Mao YK, Mistry B, Neufeld KA, Bienenstock J & Kunze W (2013). Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents. Am J Physiol Gastrointest Liver Physiol 304, G211-220.
54. Robinson DR, McNaughton PA, Evans ML & Hicks GA (2004). Characterization of the primary spinal afferent innervation of the mouse colon using retrograde labelling. Neurogastroenterol Motil 16, 113-124.
55. Rong W, Hillsley K, Davis JB, Hicks G, Winchester WJ & Grundy D (2004). Jejunal afferent nerve sensitivity in wild-type and TRPV1 knockout mice. J Physiol 560, 867-881.
56. Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E, Geboes K, Chamaillard M, Ouwehand A, Leyer G, Carcano D, Colombel JF, Ardid D & Desreumaux P (2007). Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 13, 35-37.
57. Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, Roos S & Matteuzzi D (2010). Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 126, e526-533.
58. Sinn DH, Song JH, Kim HJ, Lee JH, Son HJ, Chang DK, Kim YH, Kim JJ, Rhee JC & Rhee PL (2008). Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci 53, 2714-2718.
59. Sung V, Hiscock H, Tang ML, Mensah FK, Nation ML, Satzke C, Heine RG, Stock A, Barr RG & Wake M (2014). Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ 348, g2107.
60. Szajewska H, Gyrczuk E & Horvath A (2013). Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 162, 257-262.
61. Takahashi N, Kozai D & Mori Y (2012). TRP channels: sensors and transducers of gasotransmitter signals. Front Physiol 3, 324.
62. Tan L, Bornstein J & Anderson C (2010). The neurochemistry and innervation patterns of extrinsic sensory and sympathetic nerves in the myenteric plexus of the C57Bl6 mouse jejunum. Neuroscience 166, 564-579.
63. Thompson W (1999). Irritable bowel syndrome: a management strategy. Baillieres Best Pract Res Clin Gastroenterol 13, 453-460.
64. Tougas G & Wang L (1999). Pseudoaffective cardioautonomic responses to gastric distension in rats. Am J Physiol Regul Integr Comp Physiol 277, R272-278.
65. van der Kleij H, O'Mahony C, Shanahan F, O'Mahony L & Bienenstock J (2008). Protective effects of Lactobacillus reuteri and Bifidobacterium infantis in murine models for colitis do not involve the vagus nerve. Am J Physiol Regul Integr Comp Physiol 295, R1131-1137.
66. Vay L, Gu C & McNaughton PA (2012). The thermo-TRP ion channel family: properties and therapeutic implications. Br J Pharmacol 165, 787-801.
67. Verdu EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, Mao Y, Wang L, Rochat F & Collins SM (2006). Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55, 182-190.
68. Wang B, Mao YK, Diorio C, Pasyk M, Wu RY, Bienenstock J & Kunze WA (2010a). Luminal administration ex vivo of a live Lactobacillus species moderates mouse jejunal motility within minutes. FASEB J 24, 4078-4088.
69. Ca channel blockade have similar effects on rat colon motility and myenteric neurones. Neurogastroenterol Motil 22, 98-107, e133.
70. Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F & Quigley EM (2006). Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 101, 1581-1590.
71. Winston J, Shenoy M, Medley D, Naniwadekar A & Pasricha PJ (2007). The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology 132, 615-627.
72. Wu RY, Pasyk M, Wang B, Forsythe P, Bienenstock J, Mao YK, Sharma P, Stanisz AM & Kunze WA (2013). Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains. Neurogastroenterol Motil 25, e205-214.
73. Zhi L, Dong L, Kong D, Sun B, Sun Q, Grundy D, Zhang G & Rong W (2013). Curcumin acts via transient receptor potential vanilloid-1 receptors to inhibit gut nociception and reverses visceral hyperalgesia. Neurogastroenterol Motil 25, e429-e440.
74. Zhong F, Christianson JA, Davis BM & Bielefeldt K (2008). Dichotomizing axons in spinal and vagal afferents of the mouse stomach. Dig Dis Sci 53, 194-203.